# Competitive Analysis

This document compares the BioSignal wearable ECG device with existing solutions in the market.

## 1. Competitor Matrix

| Feature | BioSignal (Our Device) | Holter Monitor (Hospital) | Apple Watch / Smartwatches | Traditional ECG (Clinic) |
| :--- | :--- | :--- | :--- | :--- |
| **Continuous Monitoring** | ✅ 24/7 (up to 3 days) | ✅ 24-48 hours | ✅ 24/7 | ❌ 10 seconds only |
| **Battery Life** | High (Optimized by CS) | Low (Requires bulky battery) | Low (Needs daily charging) | N/A |
| **On-Device AI (TinyML)** | ✅ Yes (Privacy-preserving) | ❌ No | ✅ Yes (Cloud-based) | ❌ No |
| **Data Privacy** | High (Raw data stays on device) | High | Medium (Cloud sync) | High |
| **Form Factor** | Ultra-thin Wearable Patch | Bulky, wired device | Wristwatch | Large machine |
| **Cost** | Low (~$33 prototype) | High | High | High |

## 2. Our Unique Selling Proposition (USP)
Why is BioSignal better?
1. **Energy Efficiency:** By using **Compressive Sensing**, we reduce the data size by 70%, significantly extending battery life compared to smartwatches.
2. **Privacy-First AI:** Unlike smartwatches that send data to the cloud, our **TinyML** model runs entirely on the device.
3. **Medical-Grade Design:** While smartwatches are consumer gadgets, BioSignal is designed specifically for medical monitoring (with leads-off detection and arrhythmia alerts).

## 3. Conclusion
BioSignal bridges the gap between bulky hospital monitors and consumer smartwatches. It provides the medical accuracy of a Holter monitor with the comfort and continuous monitoring of a wearable patch.
